Conditions: Fibromyalgia
Keywords: Fibromyalgia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 1025
Healthy volunteers: no

Brief summary:
The purpose of this study was to demonstrate the efficacy and safety of milnacipran at a dosage of 100 mg/day in the treatment of the fibromyalgia syndrome or the pain associate with fibromyalgia.

Detailed description:

Arms:
arm 1: Placebo, oral administration, twice daily for 12 weeks arm 2: Milnacipran 100mg/day (50mg BID \[twice a day\])

Interventions: intervention 1: Placebo intervention 2: Milnacipran 100mg
Intervention descriptions: intervention 1: Placebo, oral administration, twice daily for 12 weeks intervention 2: Milnacipran 100mg per day (50mg BID \[twice a day\])

Protocol document: